Driehaus Capital Management’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-464,895
Closed -$14.8M 438
2021
Q1
$14.8M Buy
464,895
+76,095
+20% +$2.23M 0.22% 144
2020
Q4
$8.09M Buy
+388,800
New +$7.25M 0.13% 199
2016
Q1
Sell
-13,613
Closed -$1.38M 550
2015
Q4
$1.38M Buy
13,613
+9,271
+214% +$1.04M 0.05% 346
2015
Q3
$775K Buy
+4,342
New +$1.01M 0.03% 376
2015
Q2
Sell
-13,259
Closed -$2.62M 523
2015
Q1
$2.62M Sell
13,259
-25,020
-65% -$4.44M 0.09% 283
2014
Q4
$5.48M Sell
38,279
-202
-0.5% -$27.2K 0.22% 126
2014
Q3
$5.04M Buy
+38,481
New +$4.59M 0.19% 142

Other funds holding BHC

Driehaus Capital Management's BHC Position: Q2 2021 in Review

Driehaus Capital Management sold out of Bausch Health (BHC) in Q2 2021, closing a stake of 464,895 shares — an estimated $14.8M sold.

Driehaus Capital Management first reported a position in BHC in Q3 2014 and held it in 7 quarters. The position peaked at $14.8M in Q1 2021. 357 funds tracked by Wall St. Rank hold BHC as of Q2 2021.

  • Driehaus Capital Management reported no remaining Bausch Health position as of Q2 2021 after selling out during the quarter.
  • Driehaus Capital Management sold 464,895 Bausch Health shares in Q2 2021, an estimated $14.8M.
  • Driehaus Capital Management first reported a position in Bausch Health in Q3 2014 and held it in 7 quarters.
  • Driehaus Capital Management's Bausch Health position peaked at $14.8M in Q1 2021.
  • 357 funds tracked by Wall St. Rank held Bausch Health as of Q2 2021.

Based on Driehaus Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.